ID   HSP7C_HUMAN             Reviewed;         646 AA.
AC   P11142; Q9H3R6;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   28-JAN-2026, entry version 269.
DE   RecName: Full=Heat shock cognate 71 kDa protein {ECO:0000305};
DE            EC=3.6.4.10 {ECO:0000269|PubMed:12526792};
DE   AltName: Full=Heat shock 70 kDa protein 8;
DE   AltName: Full=Heat shock protein family A member 8;
DE   AltName: Full=Lipopolysaccharide-associated protein 1;
DE            Short=LAP-1;
DE            Short=LPS-associated protein 1;
GN   Name=HSPA8 {ECO:0000312|HGNC:HGNC:5241};
GN   Synonyms=HSC70 {ECO:0000303|Ref.3}, HSP73, HSPA10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=3037489; DOI=10.1093/nar/15.13.5181;
RA   Dworniczak B.P., Mirault M.-E.;
RT   "Structure and expression of a human gene coding for a 71 kd heat shock
RT   'cognate' protein.";
RL   Nucleic Acids Res. 15:5181-5197(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=11093761; DOI=10.1124/mol.58.6.1257;
RA   Tsukahara F., Yoshioka T., Muraki T.;
RT   "Molecular and functional characterization of HSC54, a novel variant of
RT   human heat shock cognate protein 70.";
RL   Mol. Pharmacol. 58:1257-1263(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Niswonger M.L., Berk L.R., Srivastava P.K.;
RT   "Complete coding sequence of human HSC70.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-49; 57-71; 77-102; 103-155; 160-188; 221-247;
RP   273-311; 326-342; 349-416; 424-447; 452-493; 510-517; 540-550; 570-597 AND
RP   602-646, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [6]
RP   PROTEIN SEQUENCE OF 2-49; 57-72; 78-88; 113-188; 221-247; 300-319; 326-342;
RP   349-357; 362-384; 424-447; 452-469; 510-517; 540-550 AND 584-609, CLEAVAGE
RP   OF INITIATOR METHIONINE, ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.,
RA   Bilsland A.E., Keith W.N.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 4-49; 57-71; 77-88; 113-126; 129-155; 160-187; 221-246;
RP   300-311; 329-342; 362-384; 424-447; 540-550 AND 574-583, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 50-55; 103-107 AND 580-596.
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel protein
RT   database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [9]
RP   PROTEIN SEQUENCE OF 77-86; 221-236 AND 302-311.
RX   PubMed=8713105; DOI=10.1006/bbrc.1996.1082;
RA   Egerton M., Moritz R.L., Druker B., Kelso A., Simpson R.J.;
RT   "Identification of the 70kD heat shock cognate protein (Hsc70) and alpha-
RT   actinin-1 as novel phosphotyrosine-containing proteins in T lymphocytes.";
RL   Biochem. Biophys. Res. Commun. 224:666-674(1996).
RN   [10]
RP   PROTEIN SEQUENCE OF 551-567, METHYLATION AT LYS-561, MUTAGENESIS OF
RP   LYS-561, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine methyltransferases
RT   preferentially interact with molecular chaperones to regulate their
RT   activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [11]
RP   FUNCTION.
RX   PubMed=2799391; DOI=10.1126/science.2799391;
RA   Chiang H.L., Terlecky S.R., Plant C.P., Dice J.F.;
RT   "A role for a 70-kilodalton heat shock protein in lysosomal degradation of
RT   intracellular proteins.";
RL   Science 246:382-385(1989).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=1586970; DOI=10.1247/csf.17.77;
RA   Hattori H., Liu Y.-C., Tohnai I., Ueda M., Kaneda T., Kobayashi T.,
RA   Tanabe K., Ohtsuka K.;
RT   "Intracellular localization and partial amino acid sequence of a stress-
RT   inducible 40-kDa protein in HeLa cells.";
RL   Cell Struct. Funct. 17:77-86(1992).
RN   [13]
RP   INTERACTION WITH BAG1, AND DOMAIN.
RX   PubMed=9305631; DOI=10.1093/emboj/16.16.4887;
RA   Takayama S., Bimston D.N., Matsuzawa S.-I., Freeman B.C., Aime-Sempe C.,
RA   Xie Z., Morimoto R.I., Reed J.C.;
RT   "BAG-1 modulates the chaperone activity of Hsp70/Hsc70.";
RL   EMBO J. 16:4887-4896(1997).
RN   [14]
RP   INTERACTION WITH BAG1.
RX   PubMed=9679980;
RA   Takayama S., Krajewski S., Krajewska M., Kitada S., Zapata J.M., Kochel K.,
RA   Knee D., Scudiero D., Tudor G., Miller G.J., Miyashita T., Yamada M.,
RA   Reed J.C.;
RT   "Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1
RT   and its variants in normal tissues and tumor cell lines.";
RL   Cancer Res. 58:3116-3131(1998).
RN   [15]
RP   INTERACTION WITH HSF1.
RX   PubMed=9499401; DOI=10.1101/gad.12.5.654;
RA   Shi Y., Mosser D.D., Morimoto R.I.;
RT   "Molecular chaperones as HSF1-specific transcriptional repressors.";
RL   Genes Dev. 12:654-666(1998).
RN   [16]
RP   INTERACTION WITH SV40 VP1 (MICROBIAL INFECTION).
RX   PubMed=11147964; DOI=10.1379/1466-1268(2000)005<0132:hiwsvp>2.0.co;2;
RA   Sainis L., Angelidis C., Pagoulatos G.N., Lazaridis L.;
RT   "HSC70 interactions with SV40 viral proteins differ between permissive and
RT   nonpermissive mammalian cells.";
RL   Cell Stress Chaperones 5:132-138(2000).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH CITED1.
RX   PubMed=10722728; DOI=10.1074/jbc.275.12.8825;
RA   Yahata T., de Caestecker M.P., Lechleider R.J., Andriole S., Roberts A.B.,
RA   Isselbacher K.J., Shioda T.;
RT   "The MSG1 non-DNA-binding transactivator binds to the p300/CBP
RT   coactivators, enhancing their functional link to the Smad transcription
RT   factors.";
RL   J. Biol. Chem. 275:8825-8834(2000).
RN   [18]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11559757; DOI=10.1242/jcs.114.13.2491;
RA   Agarraberes F.A., Dice J.F.;
RT   "A molecular chaperone complex at the lysosomal membrane is required for
RT   protein translocation.";
RL   J. Cell Sci. 114:2491-2499(2001).
RN   [19]
RP   FUNCTION, IDENTIFICATION AS LPS RECEPTOR, INTERACTION WITH CXCR4; GDF5 AND
RP   HSP90AA1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11276205; DOI=10.1038/86342;
RA   Triantafilou K., Triantafilou M., Dedrick R.L.;
RT   "A CD14-independent LPS receptor cluster.";
RL   Nat. Immunol. 2:338-345(2001).
RN   [20]
RP   FUNCTION, INTERACTION WITH TOMM70, AND CATALYTIC ACTIVITY.
RX   PubMed=12526792; DOI=10.1016/s0092-8674(02)01250-3;
RA   Young J.C., Hoogenraad N.J., Hartl F.U.;
RT   "Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the
RT   mitochondrial import receptor Tom70.";
RL   Cell 112:41-50(2003).
RN   [21]
RP   INTERACTION WITH PACRG.
RX   PubMed=14532270; DOI=10.1074/jbc.m309655200;
RA   Imai Y., Soda M., Murakami T., Shoji M., Abe K., Takahashi R.;
RT   "A product of the human gene adjacent to parkin is a component of Lewy
RT   bodies and suppresses Pael receptor-induced cell death.";
RL   J. Biol. Chem. 278:51901-51910(2003).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [23]
RP   INTERACTION WITH TTC1.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [24]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [25]
RP   INTERACTION WITH TSC2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15963462; DOI=10.1016/j.bbrc.2005.05.175;
RA   Nellist M., Burgers P.C., van den Ouweland A.M.W., Halley D.J.J.,
RA   Luider T.M.;
RT   "Phosphorylation and binding partner analysis of the TSC1-TSC2 complex.";
RL   Biochem. Biophys. Res. Commun. 333:818-826(2005).
RN   [26]
RP   INTERACTION WITH DNAJB2.
RX   PubMed=15936278; DOI=10.1016/j.cub.2005.04.058;
RA   Westhoff B., Chapple J.P., van der Spuy J., Hoehfeld J., Cheetham M.E.;
RT   "HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients
RT   to the proteasome.";
RL   Curr. Biol. 15:1058-1064(2005).
RN   [27]
RP   FUNCTION.
RX   PubMed=15894275; DOI=10.1016/j.immuni.2005.03.009;
RA   Zhou D., Li P., Lin Y., Lott J.M., Hislop A.D., Canaday D.H.,
RA   Brutkiewicz R.R., Blum J.S.;
RT   "Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens.";
RL   Immunity 22:571-581(2005).
RN   [28]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [29]
RP   INTERACTION WITH HERC5, AND ISGYLATION.
RX   PubMed=16815975; DOI=10.1073/pnas.0600397103;
RA   Wong J.J., Pung Y.F., Sze N.S., Chin K.C.;
RT   "HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I
RT   IFN-induced ISGylation of protein targets.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:10735-10740(2006).
RN   [30]
RP   INTERACTION WITH IGSF8.
RX   PubMed=17785435; DOI=10.1128/mcb.00180-07;
RA   Kettner S., Kalthoff F., Graf P., Priller E., Kricek F., Lindley I.,
RA   Schweighoffer T.;
RT   "EWI-2/CD316 is an inducible receptor of HSPA8 on human dendritic cells.";
RL   Mol. Cell. Biol. 27:7718-7726(2007).
RN   [31]
RP   INTERACTION WITH DNAJC9.
RX   PubMed=17182002; DOI=10.1016/j.bbrc.2006.12.013;
RA   Han C., Chen T., Li N., Yang M., Wan T., Cao X.;
RT   "HDJC9, a novel human type C DnaJ/HSP40 member interacts with and
RT   cochaperones HSP70 through the J domain.";
RL   Biochem. Biophys. Res. Commun. 353:280-285(2007).
RN   [32]
RP   INTERACTION WITH NLRP12.
RX   PubMed=17947705; DOI=10.4049/jimmunol.179.9.6291;
RA   Arthur J.C., Lich J.D., Aziz R.K., Kotb M., Ting J.P.;
RT   "Heat shock protein 90 associates with monarch-1 and regulates its ability
RT   to promote degradation of NF-kappaB-inducing kinase.";
RL   J. Immunol. 179:6291-6296(2007).
RN   [33]
RP   IDENTIFICATION IN A MRNP GRANULE COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.m600346-mcp200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [35]
RP   INTERACTION WITH TTC4.
RX   PubMed=18320024; DOI=10.1371/journal.pone.0001737;
RA   Crevel G., Bennett D., Cotterill S.;
RT   "The human TPR protein TTC4 is a putative Hsp90 co-chaperone which
RT   interacts with CDC6 and shows alterations in transformed cells.";
RL   PLoS ONE 3:E0001737-E0001737(2008).
RN   [36]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [37]
RP   IDENTIFICATION IN A COMPLEX WITH HCFC1; MKI67; EMSY; MATR3; ZNF335; TUBB2A;
RP   CCAR2; ASH2L; RBBP5 AND WDR5.
RX   PubMed=19131338; DOI=10.1074/jbc.m805872200;
RA   Garapaty S., Xu C.F., Trojer P., Mahajan M.A., Neubert T.A., Samuels H.H.;
RT   "Identification and characterization of a novel nuclear protein complex
RT   involved in nuclear hormone receptor-mediated gene regulation.";
RL   J. Biol. Chem. 284:7542-7552(2009).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [39]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-246; LYS-319; LYS-589; LYS-597
RP   AND LYS-601, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [40]
RP   INTERACTION WITH DNAJB12.
RX   PubMed=21150129; DOI=10.1247/csf.10023;
RA   Yamamoto Y.H., Kimura T., Momohara S., Takeuchi M., Tani T., Kimata Y.,
RA   Kadokura H., Kohno K.;
RT   "A novel ER J-protein DNAJB12 accelerates ER-associated degradation of
RT   membrane proteins including CFTR.";
RL   Cell Struct. Funct. 35:107-116(2010).
RN   [41]
RP   INTERACTION WITH BAG3; HSPB8 AND STUB1 IN CASA COMPLEX.
RX   PubMed=20060297; DOI=10.1016/j.cub.2009.11.022;
RA   Arndt V., Dick N., Tawo R., Dreiseidler M., Wenzel D., Hesse M.,
RA   Fuerst D.O., Saftig P., Saint R., Fleischmann B.K., Hoch M., Hoehfeld J.;
RT   "Chaperone-assisted selective autophagy is essential for muscle
RT   maintenance.";
RL   Curr. Biol. 20:143-148(2010).
RN   [42]
RP   INTERACTION WITH TRIM5.
RX   PubMed=20053985; DOI=10.1074/jbc.m109.040618;
RA   Hwang C.Y., Holl J., Rajan D., Lee Y., Kim S., Um M., Kwon K.S., Song B.;
RT   "Hsp70 interacts with the retroviral restriction factor TRIM5alpha and
RT   assists the folding of TRIM5alpha.";
RL   J. Biol. Chem. 285:7827-7837(2010).
RN   [43]
RP   IDENTIFICATION AS A COMPONENT OF THE PRP19-CDC5L COMPLEX, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=20176811; DOI=10.1128/mcb.01505-09;
RA   Grote M., Wolf E., Will C.L., Lemm I., Agafonov D.E., Schomburg A.,
RA   Fischle W., Urlaub H., Luhrmann R.;
RT   "Molecular architecture of the human Prp19/CDC5L complex.";
RL   Mol. Cell. Biol. 30:2105-2119(2010).
RN   [44]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [45]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [46]
RP   INTERACTION WITH DNAJB12.
RX   PubMed=21148293; DOI=10.1091/mbc.e10-09-0760;
RA   Grove D.E., Fan C.Y., Ren H.Y., Cyr D.M.;
RT   "The endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70 cooperate to
RT   facilitate RMA1 E3-dependent degradation of nascent CFTRDeltaF508.";
RL   Mol. Biol. Cell 22:301-314(2011).
RN   [47]
RP   INTERACTION WITH DNAJB14.
RX   PubMed=23018488; DOI=10.1247/csf.12017;
RA   Sopha P., Kadokura H., Yamamoto Y.H., Takeuchi M., Saito M., Tsuru A.,
RA   Kohno K.;
RT   "A novel mammalian ER-located J-protein, DNAJB14, can accelerate ERAD of
RT   misfolded membrane proteins.";
RL   Cell Struct. Funct. 37:177-187(2012).
RN   [48]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [49]
RP   REVIEW.
RX   PubMed=24121476; DOI=10.4161/auto.26448;
RA   Stricher F., Macri C., Ruff M., Muller S.;
RT   "HSPA8/HSC70 chaperone protein: structure, function, and chemical
RT   targeting.";
RL   Autophagy 9:1937-1954(2013).
RN   [50]
RP   SUBUNIT, AND INTERACTION WITH STUB1.
RX   PubMed=23865999; DOI=10.1021/bi4009209;
RA   Smith M.C., Scaglione K.M., Assimon V.A., Patury S., Thompson A.D.,
RA   Dickey C.A., Southworth D.R., Paulson H.L., Gestwicki J.E., Zuiderweg E.R.;
RT   "The E3 ubiquitin ligase CHIP and the molecular chaperone Hsc70 form a
RT   dynamic, tethered complex.";
RL   Biochemistry 52:5354-5364(2013).
RN   [51]
RP   INTERACTION WITH FOXP3.
RX   PubMed=23973223; DOI=10.1016/j.immuni.2013.08.006;
RA   Chen Z., Barbi J., Bu S., Yang H.Y., Li Z., Gao Y., Jinasena D., Fu J.,
RA   Lin F., Chen C., Zhang J., Yu N., Li X., Shan Z., Nie J., Gao Z., Tian H.,
RA   Li Y., Yao Z., Zheng Y., Park B.V., Pan Z., Zhang J., Dang E., Li Z.,
RA   Wang H., Luo W., Li L., Semenza G.L., Zheng S.G., Loser K., Tsun A.,
RA   Greene M.I., Pardoll D.M., Pan F., Li B.;
RT   "The ubiquitin ligase Stub1 negatively modulates regulatory T cell
RT   suppressive activity by promoting degradation of the transcription factor
RT   Foxp3.";
RL   Immunity 39:272-285(2013).
RN   [52]
RP   METHYLATION AT LYS-561, MUTAGENESIS OF LYS-561, AND INTERACTION WITH
RP   METTL21A.
RX   PubMed=23921388; DOI=10.1074/jbc.m113.483248;
RA   Jakobsson M.E., Moen A., Bousset L., Egge-Jacobsen W., Kernstock S.,
RA   Melki R., Falnes P.O.;
RT   "Identification and characterization of a novel human methyltransferase
RT   modulating Hsp70 function through lysine methylation.";
RL   J. Biol. Chem. 288:27752-27763(2013).
RN   [53]
RP   FUNCTION IN ERAD, AND INTERACTION WITH STUB1.
RX   PubMed=23990462; DOI=10.1074/jbc.m113.479345;
RA   Matsumura Y., Sakai J., Skach W.R.;
RT   "Endoplasmic reticulum protein quality control is determined by cooperative
RT   interactions between Hsp/c70 protein and the CHIP E3 ligase.";
RL   J. Biol. Chem. 288:31069-31079(2013).
RN   [54]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329 AND SER-541, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [55]
RP   INTERACTION WITH PRKN.
RX   PubMed=24270810; DOI=10.1038/nature12748;
RA   Hasson S.A., Kane L.A., Yamano K., Huang C.H., Sliter D.A., Buehler E.,
RA   Wang C., Heman-Ackah S.M., Hessa T., Guha R., Martin S.E., Youle R.J.;
RT   "High-content genome-wide RNAi screens identify regulators of parkin
RT   upstream of mitophagy.";
RL   Nature 504:291-295(2013).
RN   [56]
RP   INTERACTION WITH DNAJC12.
RX   PubMed=24122553; DOI=10.1007/s12192-013-0471-6;
RA   Choi J., Djebbar S., Fournier A., Labrie C.;
RT   "The co-chaperone DNAJC12 binds to Hsc70 and is upregulated by endoplasmic
RT   reticulum stress.";
RL   Cell Stress Chaperones 19:439-446(2014).
RN   [57]
RP   INTERACTION WITH MLLT11.
RX   PubMed=24880125; DOI=10.1016/j.yexcr.2014.05.013;
RA   Li P., Ji M., Lu F., Zhang J., Li H., Cui T., Li Wang X., Tang D., Ji C.;
RT   "Degradation of AF1Q by chaperone-mediated autophagy.";
RL   Exp. Cell Res. 327:48-56(2014).
RN   [58]
RP   FUNCTION, AND INTERACTION WITH BAG1; BAG2; BAG3 AND HSPH1.
RX   PubMed=24318877; DOI=10.1074/jbc.m113.521997;
RA   Rauch J.N., Gestwicki J.E.;
RT   "Binding of human nucleotide exchange factors to heat shock protein 70
RT   (Hsp70) generates functionally distinct complexes in vitro.";
RL   J. Biol. Chem. 289:1402-1414(2014).
RN   [59]
RP   INTERACTION WITH RNF207.
RX   PubMed=25281747; DOI=10.1074/jbc.m114.592295;
RA   Roder K., Werdich A.A., Li W., Liu M., Kim T.Y., Organ-Darling L.E.,
RA   Moshal K.S., Hwang J.M., Lu Y., Choi B.R., MacRae C.A., Koren G.;
RT   "RING finger protein RNF207, a novel regulator of cardiac excitation.";
RL   J. Biol. Chem. 289:33730-33740(2014).
RN   [60]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [61]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-469 AND LYS-561, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [62]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-512, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [63]
RP   INTERACTION WITH DNAJB12 AND DNAJB14.
RX   PubMed=24732912; DOI=10.1371/journal.pone.0094322;
RA   Goodwin E.C., Motamedi N., Lipovsky A., Fernandez-Busnadiego R., DiMaio D.;
RT   "Expression of DNAJB12 or DNAJB14 causes coordinate invasion of the nucleus
RT   by membranes associated with a novel nuclear pore structure.";
RL   PLoS ONE 9:E94322-E94322(2014).
RN   [64]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-512, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [65]
RP   INTERACTION WITH HSPA8.
RX   PubMed=25760597; DOI=10.1107/s1399004714026881;
RA   Song J., Kose S., Watanabe A., Son S.Y., Choi S., Hong H., Yamashita E.,
RA   Park I.Y., Imamoto N., Lee S.J.;
RT   "Structural and functional analysis of Hikeshi, a new nuclear transport
RT   receptor of Hsp70s.";
RL   Acta Crystallogr. D 71:473-483(2015).
RN   [66]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [67]
RP   INTERACTION WITH DNAJC21.
RX   PubMed=27346687; DOI=10.1016/j.ajhg.2016.05.002;
RA   Tummala H., Walne A.J., Williams M., Bockett N., Collopy L., Cardoso S.,
RA   Ellison A., Wynn R., Leblanc T., Fitzgibbon J., Kelsell D.P.,
RA   van Heel D.A., Payne E., Plagnol V., Dokal I., Vulliamy T.;
RT   "DNAJC21 mutations link a cancer-prone bone marrow failure syndrome to
RT   corruption in 60S ribosome subunit maturation.";
RL   Am. J. Hum. Genet. 99:115-124(2016).
RN   [68]
RP   REVIEW.
RX   PubMed=26865365; DOI=10.1007/s12192-016-0676-6;
RA   Radons J.;
RT   "The human HSP70 family of chaperones: where do we stand?";
RL   Cell Stress Chaperones 21:379-404(2016).
RN   [69]
RP   INTERACTION WITH CDKN1B AND HTN3.
RX   PubMed=26775844; DOI=10.1016/j.bbrc.2016.01.072;
RA   Imamura Y., Wang P.L., Masuno K., Sogawa N.;
RT   "Salivary protein histatin 3 regulates cell proliferation by enhancing
RT   p27(Kip1) and heat shock cognate protein 70 ubiquitination.";
RL   Biochem. Biophys. Res. Commun. 470:269-274(2016).
RN   [70]
RP   FUNCTION, INTERACTION WITH BAG1 AND BAG3, REGION NBD, AND REGION SBD.
RX   PubMed=27474739; DOI=10.1074/jbc.m116.742502;
RA   Rauch J.N., Zuiderweg E.R., Gestwicki J.E.;
RT   "Non-canonical interactions between heat shock cognate protein 70 (Hsc70)
RT   and Bcl2-associated anthanogene (BAG) co-chaperones are important for
RT   client release.";
RL   J. Biol. Chem. 291:19848-19857(2016).
RN   [71]
RP   INTERACTION WITH HOPX; STUB1; HSP40 AND HSP90.
RX   PubMed=27708256; DOI=10.1038/ncomms12882;
RA   Seo J.H., Park J.H., Lee E.J., Vo T.T., Choi H., Kim J.Y., Jang J.K.,
RA   Wee H.J., Lee H.S., Jang S.H., Park Z.Y., Jeong J., Lee K.J., Seok S.H.,
RA   Park J.Y., Lee B.J., Lee M.N., Oh G.T., Kim K.W.;
RT   "ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding
RT   and degradation.";
RL   Nat. Commun. 7:12882-12882(2016).
RN   [72]
RP   INTERACTION WITH VGF.
RX   PubMed=28934328; DOI=10.1371/journal.pone.0185176;
RA   Akhter S., Chakraborty S., Moutinho D., Alvarez-Coiradas E., Rosa I.,
RA   Vinuela J., Dominguez E., Garcia A., Requena J.R.;
RT   "The human VGF-derived bioactive peptide TLQP-21 binds heat shock 71 kDa
RT   protein 8 (HSPA8)on the surface of SH-SY5Y cells.";
RL   PLoS ONE 12:E0185176-E0185176(2017).
RN   [73]
RP   INTERACTION WITH DNAJB12 AND DNAJB14.
RX   PubMed=27916661; DOI=10.1016/j.molcel.2016.10.027;
RA   Li K., Jiang Q., Bai X., Yang Y.F., Ruan M.Y., Cai S.Q.;
RT   "Tetrameric assembly of K(+) channels requires ER-located chaperone
RT   proteins.";
RL   Mol. Cell 65:52-65(2017).
RN   [74]
RP   INTERACTION WITH ZMYND10.
RX   PubMed=29601588; DOI=10.1371/journal.pgen.1007316;
RA   Cho K.J., Noh S.H., Han S.M., Choi W.I., Kim H.Y., Yu S., Lee J.S.,
RA   Rim J.H., Lee M.G., Hildebrandt F., Gee H.Y.;
RT   "ZMYND10 stabilizes intermediate chain proteins in the cytoplasmic pre-
RT   assembly of dynein arms.";
RL   PLoS Genet. 14:E1007316-E1007316(2018).
RN   [75]
RP   INTERACTION WITH HHV-1 TRANSCRIPTIONAL REGULATOR ICP22 (MICROBIAL
RP   INFECTION).
RX   PubMed=31748398; DOI=10.1128/jvi.01564-19;
RA   Adlakha M., Livingston C.M., Bezsonova I., Weller S.K.;
RT   "The Herpes Simplex Virus 1 Immediate Early Protein ICP22 Is a Functional
RT   Mimic of a Cellular J Protein.";
RL   J. Virol. 94:0-0(2020).
RN   [76]
RP   INTERACTION WITH DNJC9.
RX   PubMed=33857403; DOI=10.1016/j.molcel.2021.03.041;
RA   Hammond C.M., Bao H., Hendriks I.A., Carraro M., Garcia-Nieto A., Liu Y.,
RA   Reveron-Gomez N., Spanos C., Chen L., Rappsilber J., Nielsen M.L.,
RA   Patel D.J., Huang H., Groth A.;
RT   "DNAJC9 integrates heat shock molecular chaperones into the histone
RT   chaperone network.";
RL   Mol. Cell 0:0-0(2021).
RN   [77]
RP   INTERACTION WITH BAG5 AND JPH2.
RX   PubMed=35044787; DOI=10.1126/scitranslmed.abf3274;
RA   Hakui H., Kioka H., Miyashita Y., Nishimura S., Matsuoka K., Kato H.,
RA   Tsukamoto O., Kuramoto Y., Takuwa A., Takahashi Y., Saito S., Ohta K.,
RA   Asanuma H., Fu H.Y., Shinomiya H., Yamada N., Ohtani T., Sawa Y.,
RA   Kitakaze M., Takashima S., Sakata Y., Asano Y.;
RT   "Loss-of-function mutations in the co-chaperone protein BAG5 cause dilated
RT   cardiomyopathy requiring heart transplantation.";
RL   Sci. Transl. Med. 14:eabf3274-eabf3274(2022).
RN   [78]
RP   FUNCTION.
RX   PubMed=36586411; DOI=10.1016/j.molcel.2022.12.002;
RA   Wang L., Cai J., Zhao X., Ma L., Zeng P., Zhou L., Liu Y., Yang S., Cai Z.,
RA   Zhang S., Zhou L., Yang J., Liu T., Jin S., Cui J.;
RT   "Palmitoylation prevents sustained inflammation by limiting NLRP3
RT   inflammasome activation through chaperone-mediated autophagy.";
RL   Mol. Cell 0:0-0(2022).
RN   [79]
RP   INTERACTION WITH MIPEP155.
RX   PubMed=32671205; DOI=10.1126/sciadv.aaz2059;
RA   Niu L., Lou F., Sun Y., Sun L., Cai X., Liu Z., Zhou H., Wang H., Wang Z.,
RA   Bai J., Yin Q., Zhang J., Chen L., Peng D., Xu Z., Gao Y., Tang S., Fan L.,
RA   Wang H.;
RT   "A micropeptide encoded by lncRNA MIR155HG suppresses autoimmune
RT   inflammation via modulating antigen presentation.";
RL   Sci. Adv. 6:eaaz2059-eaaz2059(2020).
RN   [80]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 1-634.
RX   PubMed=19586912; DOI=10.1074/jbc.m109.033894;
RA   Kajander T., Sachs J.N., Goldman A., Regan L.;
RT   "Electrostatic interactions of Hsp-organizing protein tetratricopeptide
RT   domains with Hsp70 and Hsp90: computational analysis and protein
RT   engineering.";
RL   J. Biol. Chem. 284:25364-25374(2009).
RN   [81]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 4-381 IN COMPLEXES WITH ATP AND
RP   ATP ANALOGS.
RX   PubMed=19256508; DOI=10.1021/jm801627a;
RA   Williamson D.S., Borgognoni J., Clay A., Daniels Z., Dokurno P.,
RA   Drysdale M.J., Foloppe N., Francis G.L., Graham C.J., Howes R.,
RA   Macias A.T., Murray J.B., Parsons R., Shaw T., Surgenor A.E., Terry L.,
RA   Wang Y., Wood M., Massey A.J.;
RT   "Novel adenosine-derived inhibitors of 70 kDa heat shock protein,
RT   discovered through structure-based design.";
RL   J. Med. Chem. 52:1510-1513(2009).
RN   [82]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 4-381 IN COMPLEXES WITH ATP
RP   ANALOGS.
RX   PubMed=21526763; DOI=10.1021/jm101625x;
RA   Macias A.T., Williamson D.S., Allen N., Borgognoni J., Clay A., Daniels Z.,
RA   Dokurno P., Drysdale M.J., Francis G.L., Graham C.J., Howes R.,
RA   Matassova N., Murray J.B., Parsons R., Shaw T., Surgenor A.E., Terry L.,
RA   Wang Y., Wood M., Massey A.J.;
RT   "Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78)
RT   ATPase: insights into isoform selectivity.";
RL   J. Med. Chem. 54:4034-4041(2011).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of cellular
CC       processes, including protection of the proteome from stress, folding
CC       and transport of newly synthesized polypeptides, chaperone-mediated
CC       autophagy, activation of proteolysis of misfolded proteins, formation
CC       and dissociation of protein complexes, and antigen presentation. Plays
CC       a pivotal role in the protein quality control system, ensuring the
CC       correct folding of proteins, the re-folding of misfolded proteins and
CC       controlling the targeting of proteins for subsequent degradation
CC       (PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912,
CC       PubMed:27916661, PubMed:2799391, PubMed:36586411). This is achieved
CC       through cycles of ATP binding, ATP hydrolysis and ADP release, mediated
CC       by co-chaperones (PubMed:12526792, PubMed:21148293, PubMed:21150129,
CC       PubMed:23018488, PubMed:24732912, PubMed:27916661). The co-chaperones
CC       have been shown to not only regulate different steps of the ATPase
CC       cycle of HSP70, but they also have an individual specificity such that
CC       one co-chaperone may promote folding of a substrate while another may
CC       promote degradation (PubMed:12526792, PubMed:21148293, PubMed:21150129,
CC       PubMed:23018488, PubMed:24732912, PubMed:27916661). The affinity of
CC       HSP70 for polypeptides is regulated by its nucleotide bound state. In
CC       the ATP-bound form, it has a low affinity for substrate proteins.
CC       However, upon hydrolysis of the ATP to ADP, it undergoes a
CC       conformational change that increases its affinity for substrate
CC       proteins. HSP70 goes through repeated cycles of ATP hydrolysis and
CC       nucleotide exchange, which permits cycles of substrate binding and
CC       release. The HSP70-associated co-chaperones are of three types: J-
CC       domain co-chaperones HSP40s (stimulate ATPase hydrolysis by HSP70), the
CC       nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate
CC       conversion of HSP70 from the ADP-bound to the ATP-bound state thereby
CC       promoting substrate release), and the TPR domain chaperones such as
CC       HOPX and STUB1 (PubMed:24121476, PubMed:24318877, PubMed:26865365,
CC       PubMed:27474739). Plays a critical role in mitochondrial import,
CC       delivers preproteins to the mitochondrial import receptor TOMM70
CC       (PubMed:12526792). Acts as a repressor of transcriptional activation.
CC       Inhibits the transcriptional coactivator activity of CITED1 on Smad-
CC       mediated transcription. Component of the PRP19-CDC5L complex that forms
CC       an integral part of the spliceosome and is required for activating pre-
CC       mRNA splicing. May have a scaffolding role in the spliceosome assembly
CC       as it contacts all other components of the core complex. Binds
CC       bacterial lipopolysaccharide (LPS) and mediates LPS-induced
CC       inflammatory response, including TNF secretion by monocytes
CC       (PubMed:10722728, PubMed:11276205). Substrate recognition component in
CC       chaperone-mediated autophagy (CMA), a selective protein degradation
CC       process that mediates degradation of proteins with a -KFERQ motif:
CC       HSPA8/HSC70 specifically recognizes and binds cytosolic proteins
CC       bearing a -KFERQ motif and promotes their recruitment to the surface of
CC       the lysosome where they bind to lysosomal protein LAMP2
CC       (PubMed:11559757, PubMed:2799391, PubMed:36586411). KFERQ motif-
CC       containing proteins are eventually transported into the lysosomal lumen
CC       where they are degraded (PubMed:11559757, PubMed:2799391,
CC       PubMed:36586411). In conjunction with LAMP2, facilitates MHC class II
CC       presentation of cytoplasmic antigens by guiding antigens to the
CC       lysosomal membrane for interaction with LAMP2 which then elicits MHC
CC       class II presentation of peptides to the cell membrane
CC       (PubMed:15894275). Participates in the ER-associated degradation (ERAD)
CC       quality control pathway in conjunction with J domain-containing co-
CC       chaperones and the E3 ligase STUB1 (PubMed:23990462). It is recruited
CC       to clathrin-coated vesicles through its interaction with DNAJC6 leading
CC       to activation of HSPA8/HSC70 ATPase activity and therefore uncoating of
CC       clathrin-coated vesicles (By similarity).
CC       {ECO:0000250|UniProtKB:P19120, ECO:0000269|PubMed:10722728,
CC       ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:11559757,
CC       ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:15894275,
CC       ECO:0000269|PubMed:21148293, ECO:0000269|PubMed:21150129,
CC       ECO:0000269|PubMed:23018488, ECO:0000269|PubMed:23990462,
CC       ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24732912,
CC       ECO:0000269|PubMed:27474739, ECO:0000269|PubMed:27916661,
CC       ECO:0000269|PubMed:2799391, ECO:0000269|PubMed:36586411,
CC       ECO:0000303|PubMed:24121476, ECO:0000303|PubMed:26865365}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.10;
CC         Evidence={ECO:0000269|PubMed:12526792};
CC   -!- SUBUNIT: Component of the chaperone-assisted selective autophagy (CASA)
CC       complex consisting of BAG3, HSPA8/HSC70, HSPB8 and STUB1/CHIP
CC       (PubMed:20060297). Identified in a IGF2BP1-dependent mRNP granule
CC       complex containing untranslated mRNAs. Interacts with PACRG. Interacts
CC       with HSPH1/HSP105. Interacts with IRAK1BP1 and BAG1. Interacts with
CC       DNAJC7. Interacts with DNAJB12 (via J domain) (PubMed:21148293,
CC       PubMed:21150129, PubMed:24732912, PubMed:27916661). Interacts with
CC       DNAJB14 (via J domain) (PubMed:23018488, PubMed:24732912,
CC       PubMed:27916661). Interacts (via C-terminus) with the E3 ligase CHIP
CC       forming a 210 kDa complex of one CHIP and two HSPA8 molecules.
CC       Interacts with CITED1 (via N-terminus); the interaction suppresses the
CC       association of CITED1 to p300/CBP and Smad-mediated transcription
CC       transactivation. Component of the PRP19-CDC5L splicing complex composed
CC       of a core complex comprising a homotetramer of PRPF19, CDC5L, PLRG1 and
CC       BCAS2, and at least three less stably associated proteins CTNNBL1,
CC       CWC15 and HSPA8. Interacts with TRIM5. Part of a complex composed at
CC       least of ASH2L, EMSY, HCFC1, HSPA8, CCAR2, MATR3, MKI67, RBBP5, TUBB2A,
CC       WDR5 and ZNF335; this complex may have a histone H3-specific
CC       methyltransferase activity. Interacts with METTL21A. Following LPS
CC       binding, may form a complex with CXCR4, GDF5 and HSP90AA1. Interacts
CC       with PRKN. Interacts with FOXP3. Interacts with DNAJC9 (via J domain)
CC       (PubMed:17182002). Interacts with MLLT11 (PubMed:24880125). Interacts
CC       with RNF207 (PubMed:25281747). Interacts with DNAJC21
CC       (PubMed:27346687). Interacts with DNAJB2 (PubMed:15936278). Interacts
CC       with TTC1 (via TPR repeats) (PubMed:15708368). Interacts with SGTA (via
CC       TPR repeats) (By similarity). Interacts with HSF1 (via transactivation
CC       domain) (PubMed:9499401). Interacts with HOPX, HSP40 and HSP90
CC       (PubMed:27708256). Component of the chaperone-assisted selective
CC       autophagy (CASA) complex consisting of BAG3, HSPA8/HSC70, HSPB8 and
CC       STUB1/CHIP (PubMed:20060297). Interacts with STUB1 (PubMed:27708256).
CC       Interacts with BAG2 (PubMed:24318877). Interacts with BAG3
CC       (PubMed:24318877, PubMed:27474739). Interacts with DNAJC12
CC       (PubMed:24122553). Interacts with ZMYND10 (PubMed:29601588). Interacts
CC       with HSPC138 (PubMed:25760597). Interacts with BCL2L1, GIMAP5 and MCL1;
CC       the interaction with BCL2L1 or MCL1 is impaired in the absence of
CC       GIMAP5 (By similarity). Interacts with NLPR12 (PubMed:17947705).
CC       Interacts with TTC4 (PubMed:18320024). Interacts with TOMM70; the
CC       interaction is required for preprotein mitochondrial import
CC       (PubMed:12526792). May interact with DNJC9; the interaction seems to be
CC       histone-dependent (PubMed:33857403). Interacts with BAG5 and JPH2; the
CC       interaction with JPH2 is increased in the presence of BAG5
CC       (PubMed:35044787). Interacts with VGF-derived peptide TLQP-21
CC       (PubMed:28934328). Interacts with molecular chaperone MIPEP155 (via N-
CC       terminal ATP-binding region); the interaction results in reduced ATPase
CC       activity of HSPA8, impaired interaction of HSPA8 with HSP90 and reduced
CC       lysosomal antigen trafficking (PubMed:32671205). Interacts with CDKN1B;
CC       the interaction may be associated with susceptibility to ubiquitination
CC       (PubMed:26775844). Interacts with HTN3 peptide Hst3; the interaction
CC       enhances HSPA8-CDKN1B complex formation (PubMed:26775844). Interacts
CC       with DNAJC6 (via J domain) in an ATP-dependent manner; this interaction
CC       stimulates the HSPA8's ATPase activity. Forms a complex composed of
CC       HSPA8, CLTC and DNAJC6 (By similarity). Interacts with HSPA8; this
CC       interaction modulates migratory and antigen-presenting capacities of
CC       dendritic cells (PubMed:17785435, PubMed:20060297).
CC       {ECO:0000250|UniProtKB:P19120, ECO:0000250|UniProtKB:P63017,
CC       ECO:0000250|UniProtKB:P63018, ECO:0000269|PubMed:10722728,
CC       ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:12526792,
CC       ECO:0000269|PubMed:14532270, ECO:0000269|PubMed:15708368,
CC       ECO:0000269|PubMed:15936278, ECO:0000269|PubMed:15963462,
CC       ECO:0000269|PubMed:16815975, ECO:0000269|PubMed:17182002,
CC       ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:17785435,
CC       ECO:0000269|PubMed:17947705, ECO:0000269|PubMed:18320024,
CC       ECO:0000269|PubMed:19131338, ECO:0000269|PubMed:20053985,
CC       ECO:0000269|PubMed:20060297, ECO:0000269|PubMed:21148293,
CC       ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488,
CC       ECO:0000269|PubMed:23865999, ECO:0000269|PubMed:23921388,
CC       ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:23990462,
CC       ECO:0000269|PubMed:24122553, ECO:0000269|PubMed:24270810,
CC       ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24732912,
CC       ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:25281747,
CC       ECO:0000269|PubMed:25760597, ECO:0000269|PubMed:26775844,
CC       ECO:0000269|PubMed:27346687, ECO:0000269|PubMed:27474739,
CC       ECO:0000269|PubMed:27708256, ECO:0000269|PubMed:27916661,
CC       ECO:0000269|PubMed:28934328, ECO:0000269|PubMed:29601588,
CC       ECO:0000269|PubMed:32671205, ECO:0000269|PubMed:33857403,
CC       ECO:0000269|PubMed:35044787, ECO:0000269|PubMed:9305631,
CC       ECO:0000269|PubMed:9499401, ECO:0000269|PubMed:9679980}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with SV40 VP1.
CC       {ECO:0000269|PubMed:11147964}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human herpes virus 1
CC       (HHV-1) transcriptional regulator ICP22; this interaction recruits
CC       HSPA8/HSP40 to discrete nuclear foci. {ECO:0000269|PubMed:31748398}.
CC   -!- INTERACTION:
CC       P11142; Q8IZP0: ABI1; NbExp=2; IntAct=EBI-351896, EBI-375446;
CC       P11142; P60709: ACTB; NbExp=2; IntAct=EBI-351896, EBI-353944;
CC       P11142; Q9GZX7: AICDA; NbExp=2; IntAct=EBI-351896, EBI-3834328;
CC       P11142; P05067: APP; NbExp=8; IntAct=EBI-351896, EBI-77613;
CC       P11142; P49407: ARRB1; NbExp=4; IntAct=EBI-351896, EBI-743313;
CC       P11142; P32121: ARRB2; NbExp=4; IntAct=EBI-351896, EBI-714559;
CC       P11142; Q9NQ11: ATP13A2; NbExp=2; IntAct=EBI-351896, EBI-6308763;
CC       P11142; P54253: ATXN1; NbExp=13; IntAct=EBI-351896, EBI-930964;
CC       P11142; Q99933: BAG1; NbExp=14; IntAct=EBI-351896, EBI-1030678;
CC       P11142; O95816: BAG2; NbExp=11; IntAct=EBI-351896, EBI-355275;
CC       P11142; O95429: BAG4; NbExp=6; IntAct=EBI-351896, EBI-2949658;
CC       P11142; Q15131: CDK10; NbExp=2; IntAct=EBI-351896, EBI-1646959;
CC       P11142; P00533: EGFR; NbExp=7; IntAct=EBI-351896, EBI-297353;
CC       P11142; Q9BQI3: EIF2AK1; NbExp=2; IntAct=EBI-351896, EBI-640377;
CC       P11142; Q9H6T0: ESRP2; NbExp=2; IntAct=EBI-351896, EBI-3941182;
CC       P11142; O14976: GAK; NbExp=9; IntAct=EBI-351896, EBI-714707;
CC       P11142; P01893: HLA-H; NbExp=2; IntAct=EBI-351896, EBI-3197925;
CC       P11142; P34932: HSPA4; NbExp=8; IntAct=EBI-351896, EBI-356933;
CC       P11142; Q9NZL4: HSPBP1; NbExp=16; IntAct=EBI-351896, EBI-356763;
CC       P11142; P42858: HTT; NbExp=14; IntAct=EBI-351896, EBI-466029;
CC       P11142; Q14164: IKBKE; NbExp=2; IntAct=EBI-351896, EBI-307369;
CC       P11142; PRO_0000015820 [P01308]: INS; NbExp=2; IntAct=EBI-351896, EBI-20765227;
CC       P11142; P05412: JUN; NbExp=3; IntAct=EBI-351896, EBI-852823;
CC       P11142; P00338: LDHA; NbExp=4; IntAct=EBI-351896, EBI-372327;
CC       P11142; Q5S007: LRRK2; NbExp=6; IntAct=EBI-351896, EBI-5323863;
CC       P11142; Q99558: MAP3K14; NbExp=3; IntAct=EBI-351896, EBI-358011;
CC       P11142; P10636: MAPT; NbExp=6; IntAct=EBI-351896, EBI-366182;
CC       P11142; P10636-6: MAPT; NbExp=3; IntAct=EBI-351896, EBI-7796455;
CC       P11142; P40692: MLH1; NbExp=2; IntAct=EBI-351896, EBI-744248;
CC       P11142; P14598: NCF1; NbExp=2; IntAct=EBI-351896, EBI-395044;
CC       P11142; P57723: PCBP4; NbExp=2; IntAct=EBI-351896, EBI-947264;
CC       P11142; O60260-5: PRKN; NbExp=9; IntAct=EBI-351896, EBI-21251460;
CC       P11142; Q15428: SF3A2; NbExp=4; IntAct=EBI-351896, EBI-2462271;
CC       P11142; Q9UNE7: STUB1; NbExp=9; IntAct=EBI-351896, EBI-357085;
CC       P11142; P61764: STXBP1; NbExp=2; IntAct=EBI-351896, EBI-960169;
CC       P11142; Q15750: TAB1; NbExp=5; IntAct=EBI-351896, EBI-358643;
CC       P11142; O15273: TCAP; NbExp=4; IntAct=EBI-351896, EBI-954089;
CC       P11142; Q8TDR0: TRAF3IP1; NbExp=5; IntAct=EBI-351896, EBI-928811;
CC       P11142; O00635: TRIM38; NbExp=6; IntAct=EBI-351896, EBI-2130415;
CC       P11142; Q99614: TTC1; NbExp=2; IntAct=EBI-351896, EBI-742074;
CC       P11142; Q9ULK5: VANGL2; NbExp=2; IntAct=EBI-351896, EBI-1054279;
CC       P11142; P50552: VASP; NbExp=2; IntAct=EBI-351896, EBI-748201;
CC       P11142; Q8AZK7: EBNA-LP; Xeno; NbExp=3; IntAct=EBI-351896, EBI-1185167;
CC       P11142; P38260: FES1; Xeno; NbExp=4; IntAct=EBI-351896, EBI-21563;
CC       P11142; Q5WZW9: lpl0262; Xeno; NbExp=2; IntAct=EBI-351896, EBI-40262565;
CC       P11142; P03485: M; Xeno; NbExp=4; IntAct=EBI-351896, EBI-2547543;
CC       P11142; PRO_0000045603 [Q99IB8]; Xeno; NbExp=3; IntAct=EBI-351896, EBI-6927928;
CC       P11142-1; Q9UNE7-1: STUB1; NbExp=4; IntAct=EBI-351908, EBI-15687717;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17289661}.
CC       Melanosome {ECO:0000269|PubMed:17081065}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:1586970}. Cell membrane. Lysosome membrane
CC       {ECO:0000269|PubMed:11559757}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:11559757}; Cytoplasmic side
CC       {ECO:0000269|PubMed:11559757}. Note=Localized in cytoplasmic mRNP
CC       granules containing untranslated mRNAs (PubMed:17289661). Translocates
CC       rapidly from the cytoplasm to the nuclei, and especially to the
CC       nucleoli, upon heat shock (PubMed:1586970).
CC       {ECO:0000269|PubMed:1586970, ECO:0000269|PubMed:17289661}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11142-1; Sequence=Displayed;
CC       Name=2; Synonyms=HSC54;
CC         IsoId=P11142-2; Sequence=VSP_002427;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11276205}.
CC   -!- INDUCTION: Constitutively synthesized.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known as
CC       the ATPase domain) is responsible for binding and hydrolyzing ATP. The
CC       C-terminal substrate-binding domain (SBD) (also known as peptide-
CC       binding domain) binds to the client/substrate proteins. The two domains
CC       are allosterically coupled so that, when ATP is bound to the NBD, the
CC       SBD binds relatively weakly to clients. When ADP is bound in the NBD, a
CC       conformational change enhances the affinity of the SBD for client
CC       proteins. {ECO:0000269|PubMed:9305631}.
CC   -!- PTM: Acetylated. {ECO:0000269|Ref.5, ECO:0000269|Ref.6}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798,
CC       ECO:0000269|PubMed:16815975}.
CC   -!- PTM: Trimethylation at Lys-561 reduces fibrillar SNCA binding.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00371; CAA68445.1; -; Genomic_DNA.
DR   EMBL; AB034951; BAB18615.1; -; mRNA.
DR   EMBL; AF352832; AAK17898.1; -; mRNA.
DR   EMBL; BC016179; AAH16179.1; -; mRNA.
DR   EMBL; BC016660; AAH16660.1; -; mRNA.
DR   EMBL; BC019816; AAH19816.1; -; mRNA.
DR   CCDS; CCDS44754.1; -. [P11142-2]
DR   CCDS; CCDS8440.1; -. [P11142-1]
DR   PIR; A27077; A27077.
DR   RefSeq; NP_006588.1; NM_006597.6. [P11142-1]
DR   RefSeq; NP_694881.1; NM_153201.4. [P11142-2]
DR   RefSeq; XP_011541100.1; XM_011542798.2. [P11142-1]
DR   RefSeq; XP_054224589.1; XM_054368614.1. [P11142-1]
DR   PDB; 3AGY; X-ray; 1.85 A; C/D/F=639-646.
DR   PDB; 3AGZ; X-ray; 2.51 A; C/D/E/F=639-646.
DR   PDB; 3ESK; X-ray; 2.05 A; B=635-646.
DR   PDB; 3FZF; X-ray; 2.20 A; A=4-381.
DR   PDB; 3FZH; X-ray; 2.00 A; A=4-381.
DR   PDB; 3FZK; X-ray; 2.10 A; A=4-381.
DR   PDB; 3FZL; X-ray; 2.20 A; A=4-381.
DR   PDB; 3FZM; X-ray; 2.30 A; A=4-381.
DR   PDB; 3LDQ; X-ray; 1.90 A; A=4-381.
DR   PDB; 3M3Z; X-ray; 2.10 A; A=4-381.
DR   PDB; 4H5N; X-ray; 1.86 A; A/B=2-384.
DR   PDB; 4H5R; X-ray; 1.64 A; A/B=2-384.
DR   PDB; 4H5T; X-ray; 1.90 A; A=2-384.
DR   PDB; 4H5V; X-ray; 1.75 A; A=2-384.
DR   PDB; 4H5W; X-ray; 1.94 A; A/B=2-384.
DR   PDB; 4HWI; X-ray; 2.27 A; A=5-381.
DR   PDB; 4KBQ; X-ray; 2.91 A; C/D=541-646.
DR   PDB; 5AQF; X-ray; 1.88 A; A/C=1-381.
DR   PDB; 5AQG; X-ray; 2.24 A; A/C/E=1-381.
DR   PDB; 5AQH; X-ray; 2.00 A; A=1-381.
DR   PDB; 5AQI; X-ray; 1.98 A; A/C=1-381.
DR   PDB; 5AQJ; X-ray; 1.96 A; A/C/E=1-381.
DR   PDB; 5AQK; X-ray; 2.09 A; A=1-381.
DR   PDB; 5AQL; X-ray; 1.69 A; A/C=1-381.
DR   PDB; 5AQM; X-ray; 1.63 A; A/C=1-381.
DR   PDB; 5AQN; X-ray; 2.45 A; A/C/E=1-381.
DR   PDB; 5AQO; X-ray; 2.12 A; A/C/E=1-381.
DR   PDB; 5AQP; X-ray; 2.08 A; A/C/E=1-381.
DR   PDB; 5AQQ; X-ray; 2.72 A; A/C/E=1-381.
DR   PDB; 5AQR; X-ray; 1.91 A; A/C/E=1-381.
DR   PDB; 5AQS; X-ray; 2.00 A; A/C=1-381.
DR   PDB; 5AQT; X-ray; 1.90 A; A=1-381.
DR   PDB; 5AQU; X-ray; 1.92 A; A=1-381.
DR   PDB; 5AQV; X-ray; 1.75 A; A=1-381.
DR   PDB; 6B1I; X-ray; 2.30 A; A/B=5-381.
DR   PDB; 6B1M; X-ray; 1.90 A; A/B=5-381.
DR   PDB; 6B1N; X-ray; 1.80 A; A/B=5-381.
DR   PDB; 6ZYJ; X-ray; 1.85 A; A/B=5-384.
DR   PDBsum; 3AGY; -.
DR   PDBsum; 3AGZ; -.
DR   PDBsum; 3ESK; -.
DR   PDBsum; 3FZF; -.
DR   PDBsum; 3FZH; -.
DR   PDBsum; 3FZK; -.
DR   PDBsum; 3FZL; -.
DR   PDBsum; 3FZM; -.
DR   PDBsum; 3LDQ; -.
DR   PDBsum; 3M3Z; -.
DR   PDBsum; 4H5N; -.
DR   PDBsum; 4H5R; -.
DR   PDBsum; 4H5T; -.
DR   PDBsum; 4H5V; -.
DR   PDBsum; 4H5W; -.
DR   PDBsum; 4HWI; -.
DR   PDBsum; 4KBQ; -.
DR   PDBsum; 5AQF; -.
DR   PDBsum; 5AQG; -.
DR   PDBsum; 5AQH; -.
DR   PDBsum; 5AQI; -.
DR   PDBsum; 5AQJ; -.
DR   PDBsum; 5AQK; -.
DR   PDBsum; 5AQL; -.
DR   PDBsum; 5AQM; -.
DR   PDBsum; 5AQN; -.
DR   PDBsum; 5AQO; -.
DR   PDBsum; 5AQP; -.
DR   PDBsum; 5AQQ; -.
DR   PDBsum; 5AQR; -.
DR   PDBsum; 5AQS; -.
DR   PDBsum; 5AQT; -.
DR   PDBsum; 5AQU; -.
DR   PDBsum; 5AQV; -.
DR   PDBsum; 6B1I; -.
DR   PDBsum; 6B1M; -.
DR   PDBsum; 6B1N; -.
DR   PDBsum; 6ZYJ; -.
DR   AlphaFoldDB; P11142; -.
DR   BMRB; P11142; -.
DR   SASBDB; P11142; -.
DR   SMR; P11142; -.
DR   BioGRID; 109544; 2832.
DR   ComplexPortal; CPX-5824; NineTeen Core complex.
DR   CORUM; P11142; -.
DR   DIP; DIP-32874N; -.
DR   FunCoup; P11142; 3854.
DR   IntAct; P11142; 870.
DR   MINT; P11142; -.
DR   STRING; 9606.ENSP00000437125; -.
DR   BindingDB; P11142; -.
DR   ChEMBL; CHEMBL1275223; -.
DR   DrugBank; DB07045; (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol.
DR   DrugBank; DB11638; Artenimol.
DR   DrugBank; DB09130; Copper.
DR   DrugBank; DB01254; Dasatinib.
DR   DrugCentral; P11142; -.
DR   MoonDB; P11142; Predicted.
DR   GlyConnect; 1299; 1 N-Linked glycan (1 site).
DR   GlyCosmos; P11142; 1 site, 1 glycan.
DR   GlyGen; P11142; 9 sites, 3 N-linked glycans (4 sites), 1 O-linked glycan (5 sites).
DR   iPTMnet; P11142; -.
DR   MetOSite; P11142; -.
DR   PhosphoSitePlus; P11142; -.
DR   SwissPalm; P11142; -.
DR   BioMuta; HSPA8; -.
DR   DMDM; 123648; -.
DR   OGP; P11142; -.
DR   REPRODUCTION-2DPAGE; IPI00003865; -.
DR   jPOST; P11142; -.
DR   MassIVE; P11142; -.
DR   PaxDb; 9606-ENSP00000432083; -.
DR   PeptideAtlas; P11142; -.
DR   PRIDE; P11142; -.
DR   ProteomicsDB; 52698; -. [P11142-1]
DR   ProteomicsDB; 52699; -. [P11142-2]
DR   Pumba; P11142; -.
DR   TopDownProteomics; P11142-1; -. [P11142-1]
DR   TopDownProteomics; P11142-2; -. [P11142-2]
DR   Antibodypedia; 3675; 1143 antibodies from 43 providers.
DR   DNASU; 3312; -.
DR   Ensembl; ENST00000227378.7; ENSP00000227378.3; ENSG00000109971.15. [P11142-1]
DR   Ensembl; ENST00000453788.6; ENSP00000404372.2; ENSG00000109971.15. [P11142-2]
DR   Ensembl; ENST00000532636.5; ENSP00000437125.1; ENSG00000109971.15. [P11142-1]
DR   Ensembl; ENST00000534624.6; ENSP00000432083.1; ENSG00000109971.15. [P11142-1]
DR   GeneID; 3312; -.
DR   KEGG; hsa:3312; -.
DR   MANE-Select; ENST00000534624.6; ENSP00000432083.1; NM_006597.6; NP_006588.1.
DR   UCSC; uc001pyp.5; human. [P11142-1]
DR   AGR; HGNC:5241; -.
DR   ClinPGx; PA29507; -.
DR   CTD; 3312; -.
DR   DisGeNET; 3312; -.
DR   GeneCards; HSPA8; -.
DR   HGNC; HGNC:5241; HSPA8.
DR   HPA; ENSG00000109971; Low tissue specificity.
DR   MIM; 600816; gene.
DR   OpenTargets; ENSG00000109971; -.
DR   VEuPathDB; HostDB:ENSG00000109971; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   GeneTree; ENSGT00950000183206; -.
DR   HOGENOM; CLU_005965_3_0_1; -.
DR   InParanoid; P11142; -.
DR   OMA; AYTKNQD; -.
DR   OrthoDB; 2401965at2759; -.
DR   PAN-GO; P11142; 24 GO annotations based on evolutionary models.
DR   PhylomeDB; P11142; -.
DR   BRENDA; 7.4.2.3; 2681.
DR   PathwayCommons; P11142; -.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-447041; CHL1 interactions.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8876725; Protein methylation.
DR   Reactome; R-HSA-888590; GABA synthesis, release, reuptake and degradation.
DR   Reactome; R-HSA-9613354; Lipophagy.
DR   Reactome; R-HSA-9613829; Chaperone Mediated Autophagy.
DR   Reactome; R-HSA-9615710; Late endosomal microautophagy.
DR   Reactome; R-HSA-9828642; Respiratory syncytial virus genome transcription.
DR   Reactome; R-HSA-9833482; PKR-mediated signaling.
DR   SignaLink; P11142; -.
DR   SIGNOR; P11142; -.
DR   Agora; ENSG00000109971; -.
DR   BioGRID-ORCS; 3312; 458 hits in 1183 CRISPR screens.
DR   CD-CODE; 232F8A39; P-body.
DR   CD-CODE; 8C2F96ED; Centrosome.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; BEB5E62D; Anisosome.
DR   CD-CODE; DEE660B4; Stress granule.
DR   CD-CODE; F85A2E29; IMP1 RNP granule.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; HSPA8; human.
DR   EvolutionaryTrace; P11142; -.
DR   GeneWiki; HSPA8; -.
DR   GenomeRNAi; 3312; -.
DR   Pharos; P11142; Tchem.
DR   PRO; PR:P11142; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P11142; protein.
DR   Bgee; ENSG00000109971; Expressed in corpus callosum and 112 other cell types or tissues.
DR   ExpressionAtlas; P11142; baseline and differential.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0061202; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProt.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProt.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0098575; C:lumenal side of lysosomal membrane; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0101031; C:protein folding chaperone complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0000974; C:Prp19 complex; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005681; C:spliceosomal complex; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IDA:BHF-UCL.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IBA:GO_Central.
DR   GO; GO:0140545; F:ATP-dependent protein disaggregase activity; IDA:BHF-UCL.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0055131; F:C3HC4-type RING finger domain binding; IPI:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0044183; F:protein folding chaperone; IBA:GO_Central.
DR   GO; GO:0051087; F:protein-folding chaperone binding; IPI:ARUK-UCL.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IDA:UniProtKB.
DR   GO; GO:0048018; F:receptor ligand activity; IDA:UniProt.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0046034; P:ATP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0009267; P:cellular response to starvation; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; TAS:Reactome.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; IDA:UniProt.
DR   GO; GO:1904764; P:chaperone-mediated autophagy translocation complex disassembly; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0072318; P:clathrin coat disassembly; IDA:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; NAS:ComplexPortal.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:1900226; P:negative regulation of NLRP3 inflammasome complex assembly; IDA:UniProt.
DR   GO; GO:1902904; P:negative regulation of supramolecular fiber organization; IDA:BHF-UCL.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:UniProt.
DR   GO; GO:0160020; P:positive regulation of ferroptosis; IDA:UniProt.
DR   GO; GO:0006457; P:protein folding; NAS:UniProtKB.
DR   GO; GO:0042026; P:protein refolding; IDA:UniProtKB.
DR   GO; GO:0061740; P:protein targeting to lysosome involved in chaperone-mediated autophagy; IDA:UniProtKB.
DR   GO; GO:0061635; P:regulation of protein complex stability; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1904589; P:regulation of protein import; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0043254; P:regulation of protein-containing complex assembly; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   CDD; cd10233; ASKHA_NBD_HSP70_HSPA1; 1.
DR   FunFam; 2.60.34.10:FF:000002; Heat shock 70 kDa; 1.
DR   FunFam; 3.30.420.40:FF:000172; Heat shock 70 kDa protein; 1.
DR   FunFam; 3.30.420.40:FF:000028; heat shock 70 kDa protein-like; 1.
DR   FunFam; 3.30.420.40:FF:000135; Heat shock cognate 71 kDa protein; 1.
DR   FunFam; 3.90.640.10:FF:000134; Heat shock cognate 71 kDa protein; 1.
DR   FunFam; 1.20.1270.10:FF:000003; heat shock cognate 71 kDa protein-like; 1.
DR   FunFam; 3.30.420.40:FF:000026; Heat shock protein 70; 1.
DR   FunFam; 3.30.30.30:FF:000025; Uncharacterized protein; 1.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 3.30.30.30; -; 1.
DR   Gene3D; 3.30.420.40; -; 2.
DR   Gene3D; 3.90.640.10; Actin, Chain A, domain 4; 1.
DR   Gene3D; 2.60.34.10; Substrate Binding Domain Of DNAk, Chain A, domain 1; 1.
DR   IDEAL; IID00440; -.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   NCBIfam; NF001413; PRK00290.1; 1.
DR   PANTHER; PTHR19375; HEAT SHOCK PROTEIN 70KDA; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF53067; Actin-like ATPase domain; 2.
DR   SUPFAM; SSF100934; Heat shock protein 70kD (HSP70), C-terminal subdomain; 1.
DR   SUPFAM; SSF100920; Heat shock protein 70kD (HSP70), peptide-binding domain; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Autophagy;
KW   Cell membrane; Chaperone; Cytoplasm; Direct protein sequencing;
KW   Host-virus interaction; Hydrolase; Isopeptide bond; Lysosome; Membrane;
KW   Methylation; mRNA processing; mRNA splicing; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Proteomics identification; Reference proteome; Repressor;
KW   Spliceosome; Stress response; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.5, ECO:0000269|Ref.6,
FT                   ECO:0007744|PubMed:19413330"
FT   CHAIN           2..646
FT                   /note="Heat shock cognate 71 kDa protein"
FT                   /id="PRO_0000078270"
FT   REGION          2..386
FT                   /note="Nucleotide-binding domain (NBD)"
FT                   /evidence="ECO:0000305|PubMed:27474739"
FT   REGION          186..377
FT                   /note="Interaction with BAG1"
FT   REGION          394..509
FT                   /note="Substrate-binding domain (SBD)"
FT                   /evidence="ECO:0000305|PubMed:27474739"
FT   REGION          614..646
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        616..632
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         12..15
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         14
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         15
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         71
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         202..204
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         202
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         268..275
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         268
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         271
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         275
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         339..342
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         339
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|Ref.5, ECO:0000269|Ref.6,
FT                   ECO:0007744|PubMed:19413330"
FT   MOD_RES         108
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332"
FT   MOD_RES         246
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         319
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         319
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         328
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         469
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         512
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         512
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         524
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         541
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         561
FT                   /note="N6,N6,N6-trimethyllysine; by METTL21A; alternate"
FT                   /evidence="ECO:0000269|PubMed:23349634,
FT                   ECO:0000269|PubMed:23921388"
FT   MOD_RES         561
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         589
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         597
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         601
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   CROSSLNK        512
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        512
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:25218447"
FT   VAR_SEQ         464..616
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11093761"
FT                   /id="VSP_002427"
FT   VARIANT         32
FT                   /note="D -> Y (in dbSNP:rs11551602)"
FT                   /id="VAR_049619"
FT   VARIANT         459
FT                   /note="F -> L (in dbSNP:rs11551598)"
FT                   /id="VAR_049620"
FT   MUTAGEN         561
FT                   /note="K->R: Complete loss of in vitro methylation by
FT                   METTL21A."
FT                   /evidence="ECO:0000269|PubMed:23349634,
FT                   ECO:0000269|PubMed:23921388"
FT   STRAND          7..10
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          13..22
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          25..28
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          36..39
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          42..44
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          49..51
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           53..57
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   TURN            58..61
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           63..65
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           70..72
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           81..87
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          91..97
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          100..107
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          110..114
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           116..135
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          136..138
FT                   /evidence="ECO:0007829|PDB:5AQF"
FT   STRAND          141..146
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           152..164
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          168..174
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           175..182
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           185..187
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          188..191
FT                   /evidence="ECO:0007829|PDB:5AQL"
FT   STRAND          193..201
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          204..213
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          216..225
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           230..249
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           253..255
FT                   /evidence="ECO:0007829|PDB:3LDQ"
FT   HELIX           257..276
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          278..288
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          291..298
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           299..305
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           307..312
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           314..324
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           328..330
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          333..338
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           339..342
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           344..353
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   TURN            354..356
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   STRAND          357..360
FT                   /evidence="ECO:0007829|PDB:3FZF"
FT   TURN            365..367
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           368..380
FT                   /evidence="ECO:0007829|PDB:5AQM"
FT   HELIX           541..556
FT                   /evidence="ECO:0007829|PDB:4KBQ"
FT   HELIX           564..582
FT                   /evidence="ECO:0007829|PDB:4KBQ"
FT   HELIX           594..612
FT                   /evidence="ECO:0007829|PDB:4KBQ"
FT   HELIX           613..616
FT                   /evidence="ECO:0007829|PDB:4KBQ"
FT   STRAND          641..644
FT                   /evidence="ECO:0007829|PDB:3AGY"
SQ   SEQUENCE   646 AA;  70898 MW;  9AA27B210730670C CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVM TVLIKRNTTI
     PTKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGIPPAPRG VPQIEVTFDI
     DANGILNVSA VDKSTGKENK ITITNDKGRL SKEDIERMVQ EAEKYKAEDE KQRDKVSSKN
     SLESYAFNMK ATVEDEKLQG KINDEDKQKI LDKCNEIINW LDKNQTAEKE EFEHQQKELE
     KVCNPIITKL YQSAGGMPGG MPGGFPGGGA PPSGGASSGP TIEEVD
//
